WHO 'Deeply Concerned' Over Covid Vaccines Approved for Emergency Use Not Being Recognised in All Countries: Official
3 years, 5 months ago

WHO 'Deeply Concerned' Over Covid Vaccines Approved for Emergency Use Not Being Recognised in All Countries: Official

News 18  

The World Health Organisation is deeply concerned that COVID-19 vaccines that have proven to be effective and have been approved by the global health body for emergency use are not being recognised in all countries, an official said on Thursday. Addressing a press briefing, Dr Bruce Aylward, Senior Advisor to WHO Director General Dr Tedros Adhanom Ghebreyesus, said the organisation again calls on all countries to ensure the recognition of vaccines proven to be efficacious and safe and certainly that meet WHO Emergency Use Listing criteria. On the importance of recognising vaccines for international travel, the WHO is still deeply concerned that vaccines that have been proven efficacious, have been approved by WHO through the Emergency Use Listing procedure are not being recognised in all countries, he said. Dr Katherine O’Brien, Director of the Department of Immunisation, Vaccines and Biologicals at WHO, added that recognition of vaccines is an important issue because it is pushing people to be vaccinated with more doses than they would otherwise be recommended to receive if the vaccines that they’ve already received that are WHO Emergency Use Listed are not recognised.

India British Countries Covishield Emergency Use Vaccines Proven  emergency  india  doses  vaccines  proven  uk  official  countries  concerned  approved  vaccine  vaccinated  covid  recognised  covishield  deeply

History of this topic

Health Talk | How eliminating polio has been one of the major successes of India's Universal Immunisation Programme
4 months ago

Health Talk | How eliminating polio has been one of the major successes of India's Universal Immunisation Programme

Hindustan Times  

The World Immunisation Day is observed every year on November 10th. India is a classic example of what robust immunisation coverage against a disease can achieve in the form of the country's pulse polio programme, of which vaccination was a crucial part. India rolled out the Pulse Polio Immunization Programme on October 2 1994, and according to WHO India statement, …

Recent breakthrough in COVID-19 vaccination: Indian Immunologicals Ltd unveils first needle-free booster vaccine
6 months, 2 weeks ago

Recent breakthrough in COVID-19 vaccination: Indian Immunologicals Ltd unveils first needle-free booster vaccine

Hindustan Times  

In a recent development, Hyderabad-based Indian Immunologicals Ltd in collaboration with Griffith University in Australia has made a significant breakthrough in COVID-19 vaccination technology. Indian Immunologicals Ltd unveils first needle-free booster vaccine “This accomplishment signifies a major step forward in our battle against COVID-19. According to the press release, the innovative vaccine sports an attenuated formulation that uses advanced codon …

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines
10 months, 1 week ago

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines

News 18  

In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine manufactured by the Serum Institute of India. At a press conference, the doctors, under the banner of the Awaken India Movement, …

AstraZeneca's Covishield Showed Lowest Incidence of Side Effects in India Versus Globally, Says Top Govt Official
10 months, 1 week ago

AstraZeneca's Covishield Showed Lowest Incidence of Side Effects in India Versus Globally, Says Top Govt Official

News 18  

AstraZeneca’s vaccine has demonstrated the lowest incidence of side effects in India compared to the global average, a top government official involved in the national roll-out of Covid-19 vaccination told News18. “But only around 50 cases witnessed Thrombosis with Thrombocytopenia Syndrome — a rare side effect caused by the jab — of the 180 crore doses administered against 4 to …

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021
10 months, 1 week ago

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021

Live Mint  

New Delhi: The Serum Institute of India on Wednesday said it has stopped making and supplying covid-19 vaccine Covishield after AstraZeneca, the British drugmaker that helped develop the vaccine, announced it too was withdrawing its version of the jab worldwide. The development follows the launch of a class action suit in the UK over allegations that the UK vaccine caused …

Stopped manufacturing Covishield since December 2021, says Serum Institute
10 months, 1 week ago

Stopped manufacturing Covishield since December 2021, says Serum Institute

Hindustan Times  

Pune-based Serum Institute of India stopped manufacturing its anti-Covid-19 vaccine Covishield in 2021, according to a statement issued by the company on Wednesday after British-Swedish pharmaceutical manufacturer AstraZeneca announced it was withdrawing its vaccine against Covid, Vaxzevria, due to “commercial reasons” as demand for it decreased globally. Consequently, since December 2021, we have stopped the manufacturing and supply of additional …

AstraZeneca pulls its COVID-19 vaccine from the European market
10 months, 1 week ago

AstraZeneca pulls its COVID-19 vaccine from the European market

Associated Press  

LONDON — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator. In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn “at the request of the marketing authorization holder.” AstraZeneca’s COVID-19 vaccine was first given …

‘Safety is primary focus’: Covaxin-developer amid reports on AstraZeneca vaccine
10 months, 2 weeks ago

‘Safety is primary focus’: Covaxin-developer amid reports on AstraZeneca vaccine

Hindustan Times  

Amid reports over potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, Bharat Biotech, which developed the Covaxin, said in a statement that the vaccine was developed with a "single-minded focus on safety first." It stated that Covaxin was the "only Covid vaccine" in government of India's COVID-19 immunisation program to have conducted efficacy trials in India. "@bharatbiotech announcement - …

PM Modi's photo removed from vaccine certificates amidst Covishield controversy
10 months, 2 weeks ago

PM Modi's photo removed from vaccine certificates amidst Covishield controversy

Deccan Chronicle  

New Delhi: Amidst the ongoing controversy surrounding the Covishield vaccine, Prime Minister Narendra Modi's photograph has been removed from Covid-19 vaccine certificates. While speculation arose linking this action to AstraZeneca's acknowledgment of rare blood clotting cases associated with the vaccine, official sources have attributed it to the implementation of the election model code of conduct. The court had dismissed a …

Covishield | Plea in Supreme Court for probe panel for vaccine’s ‘risk factors’
10 months, 2 weeks ago

Covishield | Plea in Supreme Court for probe panel for vaccine’s ‘risk factors’

The Hindu  

The controversy over the safety aspects of the Covishield vaccine reached the Supreme Court on Wednesday, May 1, 2024, with a petition seeking the constitution of an expert medical panel to study the risk factors. Now after the document filed in UK court by the developer of Covishield, we are compelled to think on the risk and hazardous consequences of …

Only 7 Out 10 Lakh May Face Clotting Risk Due to Covishield: Former ICMR Scientist
10 months, 2 weeks ago

Only 7 Out 10 Lakh May Face Clotting Risk Due to Covishield: Former ICMR Scientist

News 18  

Only seven to eight individuals out of 10 lakh, who receive the coronavirus vaccine Covishield, face the risk of experiencing a rare side effect known as thrombosis thrombocytopenia syndrome. India’s top epidemiologist, former ICMR scientist Dr Raman Gangakhedkar, said those who got this vaccine have “no risk at all”. Gangakhedkar, who is known for his simplistic approach to clearing complicated …

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns
10 months, 2 weeks ago

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns

India TV News  

In response to recent concerns regarding potential rare side effects associated with the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical company has underscored its unwavering commitment to patient safety while affirming the vaccine's overall safety profile. This comes in the wake of a recent admission by AstraZeneca, the pharmaceutical company, that its Covid vaccine Covishield and Vaxzevria "can, in very rare cases, …

India eyes to increase oral polio vaccine supply
10 months, 2 weeks ago

India eyes to increase oral polio vaccine supply

Live Mint  

New Delhi: The Centre is looking to increase the manufacturing capacity of oral polio vaccine, said Union Health and Family Welfare Secretary Apurva Chander. "An agreement has been signed under which Bharat Biotech will procure drug substances for manufacturing oral polio vaccines to be supplied within India and globally. With this partnership, the capacity of BBIL to manufacture Oral Polio …

With State prod, India can be world leader in vaccines
1 year, 1 month ago

With State prod, India can be world leader in vaccines

Hindustan Times  

The World Health Organization activated its incident management support team as part of its emergency response framework on the emergence of a cluster of atypical pneumonia cases emerging from Wuhan, China, on January 1, 2020. India, the dark horse in the vaccine race, did the unexpected and against all odds, approving EUA to two vaccines — “made in India” Covishield …

Over 220 crore COVID vaccine doses administered across India, but less than 23 crore booster doses: Health Ministry data
1 year, 2 months ago

Over 220 crore COVID vaccine doses administered across India, but less than 23 crore booster doses: Health Ministry data

The Hindu  

A total of 220.67 crore COVID vaccine doses have been administered across the country as on December 21 this year, according to data released by the Health Ministry on Wednesday. However, only 22.88 crore precautionary or booster doses have been administered across the country among the eligible adult population. Despite the recent increase of people infected with the JN.1 COVID …

New COVID variant JN.1: Health Ministry says no need for booster dose
1 year, 2 months ago

New COVID variant JN.1: Health Ministry says no need for booster dose

The Hindu  

Following the Union Health Ministry direction that States be alert and prepared for any possible surge in COVID-19 cases following the emergence of the new variant JN.1, senior health officials said that there is no move to recommend administration of vaccine booster dose for India. India saw a single-day rise of 656 COVID-1 infections while the active cases have increased …

Covid in India Highlights: Maharashtra reports nine JN.1 infections
1 year, 2 months ago

Covid in India Highlights: Maharashtra reports nine JN.1 infections

Hindustan Times  

Covid in India Highlights: India logged a total of 656 fresh cases of Covid-19 infections on December 24. Former AIIMS, Delhi, director Randeep Guleria said the sub-variant JN.1 is “gradually becoming dominant” but observed that it is not causing severe infections or hospitalisations. The World Health Organisation also classified JN.1 into the Variant of Interest category, however, said there is …

COVID-19 Update: India records 260 new cases, total active at 1,828
1 year, 2 months ago

COVID-19 Update: India records 260 new cases, total active at 1,828

Live Mint  

India reported 260 new cases of COVID-19, with active cases rising to 1,828, as per the latest data from the Union Health Ministry on December 18. Centre Urges States to Heighten Vigilance The central government has written to states and union territories, urging them to maintain "continuous vigilance" in light of the recent surge in COVID-19 cases and the identification …

'Every New Wave Comes in Dec': Expert Take as JN.1 Covid-19 Variant Threatens Holiday Season
1 year, 2 months ago

'Every New Wave Comes in Dec': Expert Take as JN.1 Covid-19 Variant Threatens Holiday Season

News 18  

A growing Covid-19 variant, JN.1, has taken off this holiday season in several countries but there isn’t anything ‘alarming’ in India, co-chair at INSACOG’s advisory board, Dr Saumitra Das, told News18.com in an exclusive interaction. “We must notice that every new wave comes in the month of December or in winter, starting from the first wave to the Delta wave …

Accelerating Routine Immunization in India: Insights from Covid-19 Drive
1 year, 4 months ago

Accelerating Routine Immunization in India: Insights from Covid-19 Drive

The Quint  

In the aftermath of Covid-19 pandemic and ensuing vaccination drive in India, the country's healthcare system gained invaluable insights into strengthening routine immunization programs. Learnings for Health Sector: The drive provided crucial insights into routine immunization systems, leveraging existing infrastructure and expertise effectively. Role of MOMENTUM Routine Immunization Transformation & Equity Project: National Roll-Out Support: Initiated in August 2021, the …

How India’s Vaccine Industry Will Save Millions of Children in Africa - News18
1 year, 5 months ago

How India’s Vaccine Industry Will Save Millions of Children in Africa - News18

News 18  

On 2 October 2023, when India celebrated both Gandhi and Lal Bahadur Shastri Jayanti, there was one more reason to celebrate this year. In April 2023, almost coinciding with World Malaria Day, the West African nation Ghana approved the malaria vaccine R21, even before it was approved by the WHO. The vaccine R21 is developed at the University of Oxford …

The Vaccine War: A tale of Indian scientists' triumph over COVID-19 amid the Left's propaganda to undermine indigenous vaccine
1 year, 5 months ago

The Vaccine War: A tale of Indian scientists' triumph over COVID-19 amid the Left's propaganda to undermine indigenous vaccine

Op India  

Recalling the dreadful chapters from the year 2020 when the spread of novel coronavirus in India killed several lives, affected many businesses, and derailed the normal routine lives of almost all is difficult. But Vivek Ranjan Agnihotri, the marvellous director who earlier amazed audiences with movies like ‘The Kashmir Files’ and ‘The Tashkent Files’ has made an attempt to bring …

New Covid variant Eris detected in Maharashtra; should India be worried? What experts say
1 year, 7 months ago

New Covid variant Eris detected in Maharashtra; should India be worried? What experts say

Hindustan Times  

New Covid variant EG.5.1 or Eris that has been adding to the surge of Coronavirus cases in UK has also been causing slight increase in Coronavirus caseload in Maharashtra. The new Covid strain Eris has increased hospitalisation cases among elderly in UK and while there is no need to panic, it's imperative to keep a close watch on it. The …

A new regime: On the Emergency Use Authorisation regime in India and clinical trials
1 year, 8 months ago

A new regime: On the Emergency Use Authorisation regime in India and clinical trials

The Hindu  

Last week, the Drug Controller General of India cleared, under the provisions of ‘emergency use authorisation’, a new mRNA vaccine for COVID-19 developed by Pune-based Gennova Biopharmaceuticals, a pioneer in India in developing mRNA vaccines. More than evidence-based assessment, it was a technicality in India’s ‘New Drugs and Clinical Trials Rules, 2019’ that allowed EUA in India for COVID-19 vaccines. …

India-made mRNA vaccine priced at ₹2,292, will be available as a booster dose
1 year, 8 months ago

India-made mRNA vaccine priced at ₹2,292, will be available as a booster dose

The Hindu  

India’s first indigenously developed mRNA vaccine against the dominant Omicron variant of the COVID-19 coronavirus will cost ₹2,292, Sanjay Singh, CEO, Gennova Biopharmaceuticals, said at a press conference on June 24. The vaccine will for now only be available as a booster or “precaution dose”, that is, somebody who has already been vaccinated thrice will be ineligible as the relevant …

Bolster the US-India vaccine collaboration
1 year, 8 months ago

Bolster the US-India vaccine collaboration

Hindustan Times  

As India and the United States look to step up their strategic technology partnership, the former is in an advantageous position in the shifting collaborative paradigm — a confident democracy with a robust and resilient research and development ecosystem. Well supported by globally competitive academic research organisations such as the Indian Council for Medical Research - National Institute of Virology, …

India urges G-20 countries to join vaccine research collaborative in wake of COVID vaccine inequity
1 year, 9 months ago

India urges G-20 countries to join vaccine research collaborative in wake of COVID vaccine inequity

The Hindu  

With the COVID-19 pandemic exposing the acute inequity in vaccine development and access, the Indian government is working in partnership with two leading global non-profits to convene and build consensus among the G-20 member States and others, for a proposed Global Vaccine Research Collaborative. “International cooperation is essential to advance vaccine development for emerging pathogens, and the G-20 can serve …

India’s Winning Formula: Making Healthcare Affordable and Accessible with PPPs
1 year, 9 months ago

India’s Winning Formula: Making Healthcare Affordable and Accessible with PPPs

News 18  

In the last 75 years, India’s progress as a nation has been both inspiring and impressive. Vaccine PPPs during the Covid-19 pandemic It is during the pandemic that India gained a definite advantage in the global health space, when it administered the first dose of the indigenous Covid-19 vaccine Covaxin, in January 2021. Within a year of the emergence of …

At 14,493, India records sharp dip in daily Covid tally, logs 801 new cases
1 year, 10 months ago

At 14,493, India records sharp dip in daily Covid tally, logs 801 new cases

Hindustan Times  

India has logged 801 new coronavirus infections, while the active cases have dipped to 14,493 from 15,515, according to the Union Health Ministry data updated on Monday. According to the ministry's website, 220.66 crore doses of Covid vaccine have been administered in the country so far under the nationwide vaccination drive. The active cases now comprise 0.03 per cent of …

India is 1 of 3 countries where confidence in children’s vaccines has increased: UNICEF report
1 year, 10 months ago

India is 1 of 3 countries where confidence in children’s vaccines has increased: UNICEF report

The Hindu  

Only China, India, and Mexico, that is three out of the 55 countries studied for popular perception of the importance of vaccines for children, showed improvement as per data collected by The Vaccine Confidence Project and published by UNICEF on April 20. UNICEF India today released the agency’s global flagship report ‘The State of the World’s Children 2023: For Every …

India among countries with highest vaccine confidence. What about its neighbours
1 year, 10 months ago

India among countries with highest vaccine confidence. What about its neighbours

Hindustan Times  

UNICEF India on Thursday released the agency's global flagship report "The State of the World's Children 2023: For Every Child, Vaccination," highlighting the significance of childhood immunisation. According to Cynthia McCaffrey, UNICEF India Representative, World's Children 2023 report highlights India as one of the countries with the highest vaccine confidence in the world, "The State of the World's Children 2023 …

India restarts Covid vaccine production as new infections soar 30% in one day
1 year, 11 months ago

India restarts Covid vaccine production as new infections soar 30% in one day

The Independent  

India is ramping up its vaccine production following a rapid surge in Covid-19 cases driven by a new subvariant dubbed Arcturus. The country recorded 10,158 news Covid cases on Thursday, a 30 per cent surge in one day, according to the federal health ministry data. The company stopped manufacturing Covishield in December 2021 due to dwindling demand and a low …

Serum Institute could resume Covishield production as Covid cases rise
1 year, 11 months ago

Serum Institute could resume Covishield production as Covid cases rise

Live Mint  

The Serum Institute of India could resume production of the Covishield Covid-19 vaccine as infections rise in the country, a company spokesperson said on Wednesday. Dr Amitav Banerjee - an epidemiologist who leads DY Patil Medical College in Pune has earlier said that Covishield carried a ‘double whammy of risk’. Many would perhaps not know that Covishield carries a DNA …

India sees over 7,800 COVID cases in a day reported on April 12, 2023
1 year, 11 months ago

India sees over 7,800 COVID cases in a day reported on April 12, 2023

The Hindu  

Omicron XBB and its variants are responsible for the current surge in COVID-19 cases, but this is not a cause for worry as the severity of this variant is currently below average, with less hospitalisation, a senior Health Ministry official said on April 12. The Health Ministry source said that the current surge is not a “wave” but rather an …

Old Covid Vaccines May Have Low Efficacy; India Should Update Covid Boosters, Dr Randeep Guleria Warns
1 year, 11 months ago

Old Covid Vaccines May Have Low Efficacy; India Should Update Covid Boosters, Dr Randeep Guleria Warns

News 18  

Similar to flu shots, India may need to update its Covid-19 boosters with the latest strain of the coronavirus, former director of All India Institute of Medical Sciences, Dr Randeep Guleria told News18.com. A renowned pulmonologist, Dr Guleria said the vaccines in India are currently using the Wuhan strain or the strain which was circulating in December 2019. “But now, …

Active COVID-19 cases in India rise to 21,179
1 year, 11 months ago

Active COVID-19 cases in India rise to 21,179

The Hindu  

India logged 3,038 new coronavirus cases, while the active cases increased to 21,179, according to the Union Health Ministry data updated on Tuesday, April 4, 2023. The COVID-19 case tally was recorded at 4.47 crore The active cases now comprise 0.05 per cent of the total infections and the national COVID-19 recovery rate was recorded at 98.76 per cent, the …

India sees a surge in COVID-19 cases: Does the country need a fourth jab?
1 year, 11 months ago

India sees a surge in COVID-19 cases: Does the country need a fourth jab?

Firstpost  

India has registered 3,641 fresh cases of COVID-19 in the last 24 hours. Experts say taking a booster shot may not be very beneficial COVID-19 cases across several states in India are on the rise, thanks to XXB.1.16 – a subtype of Omicron, also a matter of concern. According to the health ministry data, India logged 3,641 new infections in …

'Force to Reckon With in Near Future': Ex-ICMR DG Praises Govt’s 'Deliberate' Call to Give Free Covid Jabs
1 year, 11 months ago

'Force to Reckon With in Near Future': Ex-ICMR DG Praises Govt’s 'Deliberate' Call to Give Free Covid Jabs

News 18  

It was the Narendra Modi government’s deliberate and concerted decision to deliver free Covid-19 vaccines to everyone in India unlike other countries where vaccines were sold at exorbitant prices, Dr Balram Bhargava, former director general of Indian Council of Medical Research, has said. “The issue of the pricing of vaccines in India was a deliberate effort of the government to …

History TV18's 'The Vial': India's COVID vaccine journey; a true success story
1 year, 11 months ago

History TV18's 'The Vial': India's COVID vaccine journey; a true success story

Firstpost  

When COVID broke out the medical community had no idea how to deal with it. ‘The Vial’ also chronicles the development of the Covishield vaccine — From isolation of the strain at Pune’s National Institute of Virology to manufacturing billions of vials of two of the world’s most effective vaccine candidates in record time to cater to the country’s massive …

Active COVID-19 cases in country climb to 7,026
1 year, 11 months ago

Active COVID-19 cases in country climb to 7,026

The Hindu  

India recorded 1,134 new coronavirus cases, while the active cases increased to 7,026, according to the Union Health Ministry data updated on March 22. The death toll climbed to 5,30,813 with five deaths with one each reported by Chhattisgarh, Delhi, Gujarat and Maharashtra and one reconciled by Kerala, the data updated at 8 am stated. The active cases now comprise …

India records 1,134 new Covid cases, active tally crosses 7,000 mark
1 year, 11 months ago

India records 1,134 new Covid cases, active tally crosses 7,000 mark

Hindustan Times  

India on Wednesday recorded a single-day rise of 1,134 new Covid cases, with the active case tally surpassing the 7,000 mark, news agency PTI reported quoting Health ministry data. The rise in Covid cases was attributed to the sudden change in season and people not taking the booster vaccine shot. The number of active cases has increased to 7,026, comprising …

‘The Vial’ trailer out: Manoj Bajpayee narrates History TV18's documentary on India’s Covid-19 vaccine journey
1 year, 11 months ago

‘The Vial’ trailer out: Manoj Bajpayee narrates History TV18's documentary on India’s Covid-19 vaccine journey

Firstpost  

India’s Covid-19 vaccination programme has proven to be the world’s largest but how did the nation, led by Prime Minister Narendra Modi, embark on this journey? To find out the details of a historic and unprecedented battle, check out History TV18’s documentary titled ‘The Vial – India’s Vaccine Story’ on March 24, 2023, at 8PM. ‘The Vial’ brings to life …

India records over 300 new Covid cases after 97 days
2 years ago

India records over 300 new Covid cases after 97 days

Hindustan Times  

India logged more than 300 fresh coronavirus cases after 97 days, while the active cases increased to 2,686, according to the Union health ministry data updated on Saturday. The country's infection tally stands at 4.46 crore The country saw a single-day rise of 334 new cases, while the death toll rose to 5,30,775 with three latest fatalities -- two reported …

Covid vaccine mission is a lesson for the world
2 years ago

Covid vaccine mission is a lesson for the world

Hindustan Times  

When Covid-19 began in early 2020, most experts predicted India could face disastrous consequences. India’s response to the pandemic highlighted the underlying strengths of our scientific and technological prowess Not only did India succeed in protecting its population, but it also sent vaccines to other countries, thus proving to the world its capability of developing the first-ever DNA vaccine and …

India saved 3.4mn people through Covid-19 vaccination drive: Report
2 years ago

India saved 3.4mn people through Covid-19 vaccination drive: Report

Hindustan Times  

India saved at least 3.4 million lives by undertaking a nationwide Covid-19 vaccination campaign at an unprecedented scale, said a new report released by the Union health minister, Mansukh Mandaviya, on Friday, adding that the vaccination campaign also yielded a positive economic impact by preventing a loss of $18.3 billion. India started its Covid vaccination drive on January 16, 2021, …

‘India’s contribution to Covid vaccines has been tremendous’: CEPI chief
2 years ago

‘India’s contribution to Covid vaccines has been tremendous’: CEPI chief

Hindustan Times  

Richard Hatchett, CEO of CEPI who is on a visit to India, spoke to HT about the country gaining attention globally by manufacturing and developing anti-Covid vaccines in less than a year, and lessons learnt from the pandemic. Did the fact that India developed and produced Covid vaccines in less than a year catch global attention? And it wasn’t just …

New rules for flyers from 6 countries visiting India kicks in: 10 things to know
2 years, 1 month ago

New rules for flyers from 6 countries visiting India kicks in: 10 things to know

Live Mint  

From today, India is lifting the mandatory Covid-19 test for travellers arriving from/via China, Singapore, Hong Kong, Korea, Thailand and Japan, as infections related to the virus have fallen sharply globally. Union Health Secretary Rajesh Bhushan, in a letter to his counterpart in the Ministry of Civil Aviation Rajiv Bansal, said his ministry was updating its 'Guidelines for International Arrivals' …

’Covishield shouldn’t have been rolled out’: Doctor flags ’severe’ side-effects
2 years, 1 month ago

’Covishield shouldn’t have been rolled out’: Doctor flags ’severe’ side-effects

Live Mint  

A well known British-Indian cardiologist has flagged the cardiovascular side effects of the Covishield vaccine. According to Dr Aseem Malhotra, the vaccine manufactured in India by the Serum Institute is ‘even worse’ than mRNA COVID-19 vaccines when it came to concerns such as heart attacks and strokes. Citing a comparison published in a peer-reviewed journal, he said that the Oxford-AstraZeneca …

India launches world’s 1st intranasal Covid vaccine: Check price, availability
2 years, 1 month ago

India launches world’s 1st intranasal Covid vaccine: Check price, availability

Hindustan Times  

The world's first made-in-India intranasal Covid-19 vaccine iNCOVACC, manufactured by Bharat Biotech, was launched on Thursday as the country marked its 74th Republic Day. Union health minister Mansukh Mandaviya launched the vaccine and emphasised India's vaccine manufacturing and innovation capability, which he said is appreciated all over the world. "As the world's first intranasal Covid-19 vaccine, this is a glorious …

Centre rolls out first nasal Covid vaccine as booster
2 years, 1 month ago

Centre rolls out first nasal Covid vaccine as booster

Hindustan Times  

India on Thursday rolled out the first nasal vaccine against Covid-19, to be administered as a primary or booster dose for adults, potentially widening the pool of people who may take a third vaccine against the infection, cutting tertiary costs, and easing pressures on supply and storage networks. “Being the world’s first intranasal Covid-19 vaccine, this marks a glorious tribute …

Discover Related